US0070256047 - Common Stock
/PRNewswire/ -- Commercial-stage women's health innovator Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced that it has successfully renegotiated the...
/PRNewswire/ -- Use of GLP-1 receptor agonists, or GLP-1s, is skyrocketing in the United States, with more than nine million prescriptions for Ozempic, Wegovy,...
Aditxt (ADTX) files prospectus for the resale of 3.79M shares of common stock, with a statement clarifying that it is not an offer to sell securities.
Health innovations company Aditxt regains compliance with Nasdaq's minimum stockholders' equity requirement, but shares drop 21.72% pre-market.
Aditxt's stock (ADTX) declined by over 10% after announcing a private placement to raise $6M for working capital, at a 26.85% discount to its previous...
Aditxt stock is up on Tuesday as investors in ADTX shares react to the company announcing plans to acquire Evofem Biosciences.
The Aditxt (NASDAQ: ADTX) stock price jumped by more than 83% on Tuesday, making it one of the best performers in Wall Street. The shares surged to a high of $9.47, its highest point since October 19th. At its peak, the stock was up by more than 195% from its lowest point in 2023. The […]
Aditxt (ADTX) shares surge as biotech company announces an agreement to acquire Evofem Biosciences (EVFM). Read more here.